127 related articles for article (PubMed ID: 27458623)
1. [Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis].
Popkova TV; Novikova DS; Nasonov EL
Ter Arkh; 2016; 88(5):93-101. PubMed ID: 27458623
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.
Song SN; Yoshizaki K
Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):307-16. PubMed ID: 25491492
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date.
Lazzerini PE; Capecchi PL; Guidelli GM; Selvi E; Acampa M; Laghi-Pasini F
Drug Des Devel Ther; 2016; 10():3083-3098. PubMed ID: 27713619
[TBL] [Abstract][Full Text] [Related]
4. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
Woodrick RS; Ruderman EM
Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628
[TBL] [Abstract][Full Text] [Related]
5. New biologics for rheumatoid arthritis.
Choy E
J R Coll Physicians Edinb; 2011 Sep; 41(3):234-7. PubMed ID: 21949922
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 in rheumatoid arthritis.
Nishimoto N
Curr Opin Rheumatol; 2006 May; 18(3):277-81. PubMed ID: 16582692
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6 inhibition - RA and beyond.
Woodrick RS; Ruderman EM
Bull NYU Hosp Jt Dis; 2011; 69(3):225-9. PubMed ID: 22035433
[TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin-6 therapy in rheumatoid arthritis.
Woodrick R; Ruderman EM
Bull NYU Hosp Jt Dis; 2010; 68(3):211-7. PubMed ID: 20969554
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis.
Syngle A; Verma I; Krishan P
Acta Reumatol Port; 2015; 40(1):85-8. PubMed ID: 24863079
[TBL] [Abstract][Full Text] [Related]
10. Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade.
Makrilakis K; Fragiadaki K; Smith J; Sfikakis PP; Kitas GD
Clin Rheumatol; 2015 Mar; 34(3):419-27. PubMed ID: 24912961
[TBL] [Abstract][Full Text] [Related]
11. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
[TBL] [Abstract][Full Text] [Related]
12. Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo.
Wright HL; Cross AL; Edwards SW; Moots RJ
Rheumatology (Oxford); 2014 Jul; 53(7):1321-31. PubMed ID: 24609058
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources.
Curtis JR; Perez-Gutthann S; Suissa S; Napalkov P; Singh N; Thompson L; Porter-Brown B;
Semin Arthritis Rheum; 2015 Feb; 44(4):381-8. PubMed ID: 25300699
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6 blockade-associated weight gain with abdominal enlargement in a patient with rheumatoid arthritis.
Younis S; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M; Slobodin G
J Clin Rheumatol; 2013 Jan; 19(1):48-9. PubMed ID: 23319026
[No Abstract] [Full Text] [Related]
15. [The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial].
Shi Q; Zhao Y; Bao CD; Li XF; Huang F; Zhu P; Li ZG; Gu JR; Zhang ZY; Zhao DB; Zhao SL; Jiang QD; Tian J; Zhang FC
Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):323-9. PubMed ID: 23925361
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab - a new step in rheumatoid arthritis treatment.
Brandão FM; Coelho P; Pinto P; Combe B
Acta Reumatol Port; 2010; 35(3):302-12. PubMed ID: 20975633
[TBL] [Abstract][Full Text] [Related]
17. Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.
Gualtierotti R; Ingegnoli F; Griffini S; Grovetti E; Meroni PL; Cugno M
Clin Exp Rheumatol; 2016; 34(3):451-8. PubMed ID: 27086948
[TBL] [Abstract][Full Text] [Related]
18. Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumab.
Lee JS; Chapman MJ; Piraino P; Lamerz J; Schindler T; Cutler P; Dernick G
Proteomics Clin Appl; 2016 Feb; 10(2):183-94. PubMed ID: 26201085
[TBL] [Abstract][Full Text] [Related]
19. The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.
Murakami M; Nishimoto N
Curr Opin Rheumatol; 2011 May; 23(3):273-7. PubMed ID: 21427577
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis.
Mircic M; Kavanaugh A
Exp Cell Res; 2011 May; 317(9):1286-92. PubMed ID: 21439276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
